After associating Vit D deficiency with cancer, researchers are now heading towards unveiling other health risks associated with decreased levels of vitamin D. National Institute of Mental Health states Vit D deficiency increases the risk of schizophrenia. Schizophrenia is commonly characterised by delusions, cognitive problems and hallucinations.
Older researches figure out the increasing prevalence of vitamin-D deficiency mediated schizophrenia in areas where there is minimum or no sunlight.
Must Read: Five basic exercises that everyone can do
Vit D deficiency increases the risk of schizophrenia
Findings of new research worked at Aarhus University (Denmark), and University of Queensland (Brisbane, Australia) focuses on newborn babies.
This study indicates that the newborn babies with a lower level of vitamin D are more likely to develop schizophrenia somewhere in the later stage of their life. The findings of this research analysis mark its presence in Scientific Journal. Further, the report states that newborns with vitamin D deficiency are responsible for nearly 8 per cent of Schizophrenia cases prevailing in the country.
The progress of the scientific analysis:
This study began with the review of around 2602 Denmark natives. Their vitamin D levels dating back to the period from 1981 to 2000 were analysed. All these people were gradually found to develop schizophrenia in the early stages of their childhood.
Must Read: Methods to calculate your calories
This data was subsequently compared with the data obtained from schizophrenia-free participants.
On a comparative evaluation, it was found that those with a vitamin D deficiency exhibited a risk of developing schizophrenia (44 per cent) in the later stage of their life.
Author further states that this vitamin D deficiency is responsible for nearly 8 per cent of the diagnostic cases of schizophrenia in newborn.
If vitamin D levels of pregnant women are detected and controlled at its initial stage, it may further assist in managing the schizophrenic development in their children. This is because the developing foetus is entirely dependent on his mother’s vitamin D reserves. Hence, it goes in hand with the role of folate supplementation assisting in the reduction of spina bifida development. Likewise, optimising the levels of vitamin D in pregnant women is beneficiary for her developing foetus.
The future of this research study indicates a promising clinical trial assessment for evaluating the administration of vitamin D supplements to pregnant and lactating mothers. This study will concentrate on assessing the role of vitamin D optimisation to protect newborn babies from neurodevelopmental conditions.
Thus, present research on whether Vit D deficiency increases the risk of schizophrenia or not has a long way to go with the clinical trials of Vit D supplement evaluation.